Precigen is trading 4.03% lower at $8.21 on October 1, 2026, with no company-specific announcement explaining the decline identified in available reporting.
- Its investor-relations press-release page lists September 21 as its latest release.
- Shares rose 6.34% to $8.56 on September 30; a pullback or profit-taking is plausible but unconfirmed.
- Major indices are essentially flat in the supplied market context, offering no clear broad-market explanation.